Omar Mamlouk

1.3k total citations
33 papers, 476 citations indexed

About

Omar Mamlouk is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Nephrology. According to data from OpenAlex, Omar Mamlouk has authored 33 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Nephrology. Recurrent topics in Omar Mamlouk's work include Cancer Immunotherapy and Biomarkers (10 papers), Renal Diseases and Glomerulopathies (6 papers) and Renal cell carcinoma treatment (4 papers). Omar Mamlouk is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Renal Diseases and Glomerulopathies (6 papers) and Renal cell carcinoma treatment (4 papers). Omar Mamlouk collaborates with scholars based in United States, Egypt and France. Omar Mamlouk's co-authors include Ala Abudayyeh, Jamie S. Lin, Maen Abdelrahim, Noha Abdel‐Wahab, William F. Glass, Cassian Yee, Umut Selamet, Amanda Tchakarov, Adi Diab and Biruh Workeneh and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Kidney International.

In The Last Decade

Omar Mamlouk

24 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Omar Mamlouk United States 9 344 158 106 70 69 33 476
Amanda Tchakarov United States 8 260 0.8× 137 0.9× 90 0.8× 40 0.6× 75 1.1× 34 405
J-L. Canon Belgium 9 264 0.8× 119 0.8× 47 0.4× 41 0.6× 31 0.4× 29 406
L Rivabella Italy 7 58 0.2× 81 0.5× 133 1.3× 37 0.5× 114 1.7× 14 397
Peter Bojko Germany 13 181 0.5× 58 0.4× 23 0.2× 43 0.6× 86 1.2× 37 523
Kichul Ko United States 12 75 0.2× 59 0.4× 158 1.5× 26 0.4× 253 3.7× 20 498
María L. Picazo Spain 10 38 0.1× 103 0.7× 138 1.3× 34 0.5× 138 2.0× 26 369
Marion Sternbach Canada 10 126 0.4× 50 0.3× 85 0.8× 90 1.3× 138 2.0× 17 529
Jere T. W. Licciardello United States 7 194 0.6× 160 1.0× 20 0.2× 46 0.7× 55 0.8× 8 463
Jacques P. Pourrat France 7 103 0.3× 63 0.4× 23 0.2× 65 0.9× 46 0.7× 12 381
Michael Borofsky United States 8 119 0.3× 48 0.3× 206 1.9× 84 1.2× 59 0.9× 15 447

Countries citing papers authored by Omar Mamlouk

Since Specialization
Citations

This map shows the geographic impact of Omar Mamlouk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omar Mamlouk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omar Mamlouk more than expected).

Fields of papers citing papers by Omar Mamlouk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Omar Mamlouk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omar Mamlouk. The network helps show where Omar Mamlouk may publish in the future.

Co-authorship network of co-authors of Omar Mamlouk

This figure shows the co-authorship network connecting the top 25 collaborators of Omar Mamlouk. A scholar is included among the top collaborators of Omar Mamlouk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Omar Mamlouk. Omar Mamlouk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Selamet, Umut, Omar Mamlouk, Juhee Song, et al.. (2023). Infliximab for Treatment of Immune Adverse Events and Its Impact on Tumor Response. Cancers. 15(21). 5181–5181. 8 indexed citations
2.
Mamlouk, Omar & Farhad R. Danesh. (2023). Immune Checkpoint Inhibitor-Associated Nephrotoxicity. ˜The œNephron journals/Nephron journals. 148(1). 11–15. 3 indexed citations
3.
Tchakarov, Amanda, et al.. (2022). BK Nephropathy in Hematopoietic Stem Cell Transplant Patients: An Upcoming Challenge. Journal of the American Society of Nephrology. 33(11S). 844–844.
4.
Weng, Julius, Jaffer A. Ajani, M Murphy, et al.. (2022). Immunotherapy Recall: Chemoradiation-Induced Reactivation of Immune Checkpoint Inhibitor Nephritis. JCO Precision Oncology. 6(6). e2200049–e2200049. 1 indexed citations
5.
Msaouel, Pavlos, et al.. (2021). Treatment of PLA2R-Negative Membranous Nephropathy in the Setting of Immune Checkpoint Inhibitor and Renal Cell Carcinoma. Journal of the American Society of Nephrology. 32(10S). 575–575.
6.
Mamlouk, Omar, et al.. (2021). Hypophosphatemia in cancer patients. Clinical Kidney Journal. 14(11). 2304–2315. 21 indexed citations
7.
Mamlouk, Omar, et al.. (2021). Lupus-Like Glomerulonephritis Associated With Regorafenib, a Multikinase Inhibitor. Kidney Medicine. 3(2). 294–298. 5 indexed citations
8.
9.
Mamlouk, Omar, et al.. (2021). Clinical characteristics and outcomes of cancer patients with chronic kidney disease and coronavirus disease 2019.. Journal of Clinical Oncology. 39(15_suppl). e18815–e18815.
10.
Mamlouk, Omar, Ranjit Nair, Swaminathan P. Iyer, et al.. (2020). Safety of CAR T-cell therapy in kidney transplant recipients. Blood. 137(18). 2558–2562. 38 indexed citations
11.
Mamlouk, Omar, et al.. (2020). Selinexor-associated hyponatremia: single-center, real-world data. Kidney International. 98(3). 789–791. 11 indexed citations
12.
Lin, Jamie S., Nicolas L. Palaskas, Omar Mamlouk, et al.. (2020). Immune Checkpoint Inhibitor-Induced Renal and Cardiac Sarcoidosis. Journal of the American Society of Nephrology. 31(10S). 849–849.
13.
Mamlouk, Omar, Jamie S. Lin, Maen Abdelrahim, et al.. (2020). Checkpoint Inhibitor-Related Renal Vasculitis and Use of Rituximab. Journal of the American Society of Nephrology. 31(10S). 662–662. 2 indexed citations
14.
Lin, Jamie S., et al.. (2020). Immune Checkpoint Inhibitor-Induced p-ANCA Multiorgan Vasculitis. Journal of the American Society of Nephrology. 31(10S). 669–669.
15.
Lin, Jamie S., Daniel Wang, Omar Mamlouk, William F. Glass, & Ala Abudayyeh. (2020). Immune Checkpoint Inhibitor-Associated Reactivation of Primary Membranous Nephropathy Responsive to Rituximab. Journal of the American Society of Nephrology. 31(10S). 670–670. 3 indexed citations
16.
Mamlouk, Omar, Jamie S. Lin, Maen Abdelrahim, et al.. (2020). Checkpoint inhibitor-related renal vasculitis and use of rituximab. Journal for ImmunoTherapy of Cancer. 8(2). e000750–e000750. 33 indexed citations
17.
Mamlouk, Omar, Umut Selamet, Maen Abdelrahim, et al.. (2019). Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience. Journal for ImmunoTherapy of Cancer. 7(1). 2–2. 199 indexed citations
18.
Mamlouk, Omar & Ala Abudayyeh. (2019). Cancer immunotherapy and its renal effects. 3(3). 151–159. 5 indexed citations
19.
Mamlouk, Omar, Pichumani Balagurumoorthy, Ketai Wang, S. James Adelstein, & Amin I. Kassis. (2012). Bystander effect in tumor cells produced by Iodine-125 labeled human lymphocytes. International Journal of Radiation Biology. 88(12). 1019–1027. 8 indexed citations
20.
Mamlouk, Omar, et al.. (2000). [CT and MR imaging of a solitary fibrous tumor of the thigh].. PubMed. 81(11). 1643–6. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amanda Tchakarov Breakdown of academic impact, for papers by J-L. Canon Breakdown of academic impact, for papers by L Rivabella Breakdown of academic impact, for papers by Peter Bojko Breakdown of academic impact, for papers by Kichul Ko Breakdown of academic impact, for papers by María L. Picazo Breakdown of academic impact, for papers by Marion Sternbach Breakdown of academic impact, for papers by Jere T. W. Licciardello Breakdown of academic impact, for papers by Jacques P. Pourrat Breakdown of academic impact, for papers by Michael Borofsky
Rankless by CCL
2026